Ken Griffin Moon Lake Immunotherapeutics Put Options Transaction History

Citadel Advisors LLC

  • $509 Billion
  • Q1 2024

Put Options

3 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q1 2024

May 15, 2024
SELL
$43.78 - $63.86 $985,050 - $1.44 Million
-22,500 Reduced 47.07%
25,300 $1.27 Million
Q4 2023

Feb 14, 2024
BUY
$36.35 - $63.02 $497,995 - $863,374
13,700 Added 40.18%
47,800 $2.89 Million
Q3 2023

Nov 14, 2023
BUY
$48.35 - $61.26 $1.65 Million - $2.09 Million
34,100 New
34,100 $1.94 Million

Others Institutions Holding MLTX

# of Institutions
135
Shares Held
56M
Call Options Held
379K
Put Options Held
402K
View Full List

About MoonLake Immunotherapeutics

MLTX Quotes by TradingView
  • Ticker MLTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 36,925,600
  • Market Cap $1.62B
  • Description
  • MoonLake Immunotherapeutics, a clinical-stage biopharmaceutical company, engages in developing therapies. It is developing Sonelokimab, a novel investigational Nanobody therapy for the treatment of inflammation. The company is involved in conducting Phase II trials for hidradenitis suppurativa, psoriatic arthritis, ankylosing spondylitis, or rad...
More about MLTX
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email